Skip to main content
Clinical Trials/NCT06279052
NCT06279052
Not yet recruiting
Not Applicable

What Projections Towards the Future During a Period of Transition? A Qualitative Study of Adolescents With Prader-Willi Syndrome

University Hospital, Toulouse1 site in 1 country20 target enrollmentMarch 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prader-Willi Syndrome
Sponsor
University Hospital, Toulouse
Enrollment
20
Locations
1
Primary Endpoint
Experience of the disease and aspirations regarding the future
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

Single-center, cross-sectional qualitative study seeking to collect the experience of adolescence and the transition to adulthood of people affected by Prader-Willi syndrome in a population. To do this, the present will carry out a qualitative study with a reflexive thematic analysis of the data collected through semi-structured interviews using an interview guide.

Registry
clinicaltrials.gov
Start Date
March 1, 2024
End Date
December 1, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with genetically confirmed Prader-Willi syndrome
  • Patients affiliated or beneficiaries of a social security system
  • Patients known and followed by the reference center, presenting sufficient intellectual skills to answer the interview questions

Exclusion Criteria

  • Refusal of family participation (if minor)
  • Refusal of participation by the patient or his guardian (if of legal age)

Outcomes

Primary Outcomes

Experience of the disease and aspirations regarding the future

Time Frame: 1 hour

The main objective of this study is to explore their experience of the disease and their aspirations regarding their future in a population of older adolescents and young adults with Prader-Willi syndrome. A questionnaire created by the clinical investigator containing personal questions will be applied to all patients. There is no scale.

Study Sites (1)

Loading locations...

Similar Trials